As of 29 January 2026, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of multiple micronutrient supplement (MMS) film-coated tablet for the prevention of vitamin and mineral deficiencies, improvement of iron status, and reduction of anemia among pregnant and lactating women. The HTA Council hereby releases its preliminary recommendation on the said health technology for stakeholder feedback and comments from 29 January to 12 February 2026.

Based on current evidence, as a preliminary recommendation, the HTA Council recommends the government financing of multiple micronutrient supplement (MMS) film-coated tablet.

For the supporting evidence reviewed and discussed by the HTA Council, please refer to the document below.

All comments, inputs, and/or appeals on the above preliminary recommendation may be submitted until 12 February 2026 (Thursday), for the consideration of the HTA Council, through email at hta@dost.gov.ph. Please use the prescribed form for appeals indicated in the official HTA Philippines website [https://hta.dost.gov.ph/appeals-2/]. Appeals not following the prescribed format, and those submitted beyond the deadline shall not be entertained.